{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:12:06Z","timestamp":1790788326043,"version":"4.1.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"am","delay-in-days":264,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.bbagen.2020.129652","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T04:15:24Z","timestamp":1591330524000},"page":"129652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["CDG biochemical screening: Where do we stand?"],"prefix":"10.1016","volume":"1864","author":[{"given":"Arnaud","family":"Bruneel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Cholet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N Thuy","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Duc","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Fenaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0304-4165(99)00165-8","article-title":"On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database","volume":"1473","author":"Apweiler","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2020.129652_bb0010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10719-015-9626-2","article-title":"Human plasma protein N-glycosylation","volume":"33","author":"Clerc","year":"2016","journal-title":"Glycoconj. J."},{"issue":"4","key":"10.1016\/j.bbagen.2020.129652_bb0015","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1373\/clinchem.2005.063040","article-title":"Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: a review","volume":"52","author":"Wopereis","year":"2006","journal-title":"Clin. Chem."},{"issue":"2\u20133","key":"10.1016\/j.bbagen.2020.129652_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0009-8981(84)90059-7","article-title":"Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome","volume":"144","author":"Jaeken","year":"1984","journal-title":"Clin. Chim. Acta"},{"issue":"11","key":"10.1016\/j.bbagen.2020.129652_bb0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ejmg.2017.10.012","article-title":"Congenital disorders of glycosylation (CDG): quo vadis?","volume":"61","author":"P\u00e9anne","year":"2018","journal-title":"Eur J Med Genet."},{"issue":"10","key":"10.1016\/j.bbagen.2020.129652_bb0030","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1651-2227.2002.tb00101.x","article-title":"Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency","volume":"91","author":"Harms","year":"2002","journal-title":"Acta Paediatr."},{"issue":"5","key":"10.1016\/j.bbagen.2020.129652_bb0035","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/ijms19051304","article-title":"CDG therapies: from bench to bedside","volume":"19","author":"Brasil","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbagen.2020.129652_bb0040","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ana.25457","article-title":"AZATAX: acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG)","volume":"85","author":"Mart\u00ednez-Monseny","year":"2019","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.bbagen.2020.129652_bb0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10545-011-9370-0","article-title":"How to find and diagnose a CDG due to defective N-glycosylation","volume":"34","author":"Lefeber","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.bbagen.2020.129652_bb0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1359-6446(04)03333-1","article-title":"Transferrin: structure, function and potential therapeutic actions","volume":"10","author":"Gomme","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"12","key":"10.1016\/j.bbagen.2020.129652_bb0055","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/clinchem\/37.12.2029","article-title":"Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed","volume":"37","author":"Stibler","year":"1991","journal-title":"Clin. Chem."},{"issue":"1\u20132","key":"10.1016\/j.bbagen.2020.129652_bb0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cca.2007.10.011","article-title":"Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker","volume":"388","author":"Bergstr\u00f6m","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbagen.2020.129652_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cca.2016.05.016","article-title":"Standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin (CDT)","volume":"459","author":"Helander","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2018.11.003","article-title":"The challenge of CDG diagnosis","volume":"126","author":"Francisco","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbagen.2020.129652_bb0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.trsl.2018.04.008","article-title":"Intact transferrin and total plasma glycoprofiling for diagnosis and therapy monitoring in phosphoglucomutase-I deficiency","volume":"199","author":"Abu Bakar","year":"2018","journal-title":"Transl. Res."},{"issue":"7","key":"10.1016\/j.bbagen.2020.129652_bb0080","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/clinchem\/47.7.1225","article-title":"Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse","volume":"47","author":"Helander","year":"2001","journal-title":"Clin. Chem."},{"issue":"9","key":"10.1016\/j.bbagen.2020.129652_bb0085","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1016\/S0021-9258(19)85632-6","article-title":"Studies on the oligosaccharide chains of human alpha 1-protease inhibitor. II. Structure of oligosaccharides","volume":"255","author":"Mega","year":"1980","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbagen.2020.129652_bb0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/glycob\/cwg026","article-title":"The underglycosylation of plasma alpha 1-antitrypsin in congenital disorders of glycosylation type I is not random","volume":"13","author":"Mills","year":"2003","journal-title":"Glycobiology."},{"issue":"5","key":"10.1016\/j.bbagen.2020.129652_bb0095","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/glycob\/5.5.503","article-title":"Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndrome","volume":"5","author":"Krasnewich","year":"1995","journal-title":"Glycobiology."},{"issue":"5","key":"10.1016\/j.bbagen.2020.129652_bb0100","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10545-012-9531-9","article-title":"Screening for congenital disorders of glycosylation in the first weeks of life","volume":"36","author":"Thiel","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.bbagen.2020.129652_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0009-8981(96)06379-6","article-title":"Diagnostic value of Western blotting in carbohydrate-deficient glycoprotein syndrome","volume":"254","author":"Seta","year":"1996","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbagen.2020.129652_bb0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cca.2017.04.022","article-title":"Two-dimensional electrophoresis highlights haptoglobin beta chain as an additional biomarker of congenital disorders of glycosylation","volume":"470","author":"Bruneel","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.bbagen.2020.129652_bb0115","first-page":"3744","article-title":"Thyroid function tests and characterization of thyroxine-binding globulin in the carbohydrate-deficient glycoprotein syndrome type I","volume":"80","author":"Macchia","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00365519850186832","article-title":"Isoforms and levels of transferrin, antithrombin, a1-antitrypsin and thyroxine-binding globulin in 48 patients with carbohydrate-deficient glycoprotein syndrome type I","volume":"58","author":"Stibler","year":"1998","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.bbagen.2020.129652_bb0125","first-page":"55","article-title":"Global serum glycoform profiling for the investigation of dystroglycanopathies & congenital disorders of glycosylation","volume":"7","author":"Heywood","year":"2016","journal-title":"Mol Genet Metab Rep."},{"issue":"9","key":"10.1016\/j.bbagen.2020.129652_bb0130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/glycob\/cwg079","article-title":"Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis","volume":"13","author":"Butler","year":"2003","journal-title":"Glycobiology."},{"issue":"17","key":"10.1016\/j.bbagen.2020.129652_bb0135","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJMoa1302846","article-title":"Glycosylation, hypogammaglobulinemia, and resistance to viral infections","volume":"370","author":"Sadat","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bbagen.2020.129652_bb0140","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/jth.14559","article-title":"Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficiencies","volume":"17","author":"Pascreau","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.bbagen.2020.129652_bb0145","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/jth.13372","article-title":"Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect","volume":"14","author":"de la Morena-Barrio","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.bbagen.2020.129652_bb0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3324\/haematol.2018.211326","article-title":"MPI-CDG with transient hypoglycosylation and antithrombin deficiency","volume":"104","author":"de la Morena-Barrio","year":"2019","journal-title":"Haematologica."},{"issue":"24","key":"10.1016\/j.bbagen.2020.129652_bb0155","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1002\/elps.201800021","article-title":"Complementarity of electrophoretic, mass spectrometric, and gene sequencing techniques for the diagnosis and characterization of congenital disorders of glycosylation","volume":"39","author":"Bruneel","year":"2018","journal-title":"Electrophoresis."},{"issue":"5","key":"10.1016\/j.bbagen.2020.129652_bb0160","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2018.296780","article-title":"Increased Clinical Sensitivity and Specificity of Plasma Protein N-Glycan Profiling for Diagnosing Congenital Disorders of Glycosylation by Use of Flow Injection-Electrospray Ionization-Quadrupole Time-of-Flight Mass Spectrometry","volume":"65","author":"Chen","year":"2019","journal-title":"Clin. Chem."},{"issue":"24","key":"10.1016\/j.bbagen.2020.129652_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/elps.201800020","article-title":"Use of Endoglycosidase H as a diagnostic tool for MAN1B1-CDG patients","volume":"39","author":"Duvet","year":"2018","journal-title":"Electrophoresis"},{"issue":"17","key":"10.1016\/j.bbagen.2020.129652_bb0170","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1093\/hmg\/ddy213","article-title":"Rodrigues pinto Osorio G, brand-Arzamendi K, et al. integrating glycomics and genomics uncovers SLC10A7 as essential factor for bone mineralization by regulating post-Golgi protein transport and glycosylation","volume":"27","author":"Ashikov","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"22","key":"10.1016\/j.bbagen.2020.129652_bb0175","doi-asserted-by":"crossref","first-page":"18210","DOI":"10.1074\/jbc.M112.355677","article-title":"Identification of intercellular cell adhesion molecule 1 (ICAM-1) as a Hypoglycosylation marker in congenital disorders of glycosylation cells","volume":"287","author":"He","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbagen.2020.129652_bb0180","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1210\/jc.2016-3443","article-title":"Galactose supplementation in patients with TMEM165-CDG rescues the glycosylation defects","volume":"102","author":"Morelle","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bbagen.2020.129652_bb0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOL.0000000000000502","article-title":"Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism","volume":"29","author":"Ramms","year":"2018","journal-title":"Curr. Opin. Lipidol."},{"issue":"11","key":"10.1016\/j.bbagen.2020.129652_bb0190","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1373\/clinchem.2003.022541","article-title":"Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis","volume":"49","author":"Wopereis","year":"2003","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.bbagen.2020.129652_bb0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/prca.200600777","article-title":"Two-dimensional gel electrophoresis of apolipoprotein C-III and other serum glycoproteins for the combined screening of human congenital disorders of O- and N-glycosylation","volume":"1","author":"Bruneel","year":"2007","journal-title":"Proteomics Clin. Appl."},{"issue":"5","key":"10.1016\/j.bbagen.2020.129652_bb0200","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1021\/pr400136p","article-title":"Identification of new apolipoprotein-CIII glycoforms with ultrahigh resolution MALDI-FTICR mass spectrometry of human sera","volume":"12","author":"Nicolardi","year":"2013","journal-title":"J. Proteome Res."},{"issue":"2","key":"10.1016\/j.bbagen.2020.129652_bb0205","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1021\/pr800751x","article-title":"O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease","volume":"8","author":"Harvey","year":"2009","journal-title":"J. Proteome Res."},{"issue":"7\u20138","key":"10.1016\/j.bbagen.2020.129652_bb0210","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/prca.201400187","article-title":"MALDI-TOF MS applied to apoC-III glycoforms of patients with congenital disorders affecting O-glycosylation. Comparison with two-dimensional electrophoresis","volume":"9","author":"Yen-Nicola\u00ff","year":"2015","journal-title":"Proteomics Clin. Appl."},{"issue":"2","key":"10.1016\/j.bbagen.2020.129652_bb0215","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajhg.2015.12.010","article-title":"CCDC115 deficiency causes a disorder of Golgi homeostasis with abnormal protein glycosylation","volume":"98","author":"Jansen","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.bbagen.2020.129652_bb0220","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/brain\/awaa063","article-title":"Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function","volume":"143","author":"Zilmer","year":"2020","journal-title":"Brain."},{"issue":"Pt 1","key":"10.1016\/j.bbagen.2020.129652_bb0225","first-page":"1","article-title":"The inter-alpha-inhibitor family: from structure to regulation","volume":"315","author":"Salier","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2020.129652_bb0230","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cca.2018.06.044","article-title":"Serum bikunin is a biomarker of linkeropathies","volume":"485","author":"Bruneel","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0235","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bbrc.2009.11.121","article-title":"Differences in gene expression of human xylosyltransferases and determination of acceptor specificities for various proteoglycans","volume":"391","author":"Roch","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bbagen.2020.129652_bb0240","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.bbagen.2020.129652_bb0245","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.bbagen.2017.06.024","article-title":"Glycosylation with ribitol-phosphate in mammals: new insights into the O -mannosyl glycan","volume":"1861","author":"Manya","year":"2017","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0250","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JND-140047","article-title":"Dystroglycanopathies: about numerous genes involved in glycosylation of one single glycoprotein","volume":"2","author":"Bouchet-S\u00e9raphin","year":"2015","journal-title":"J Neuromuscul Dis."},{"issue":"4","key":"10.1016\/j.bbagen.2020.129652_bb0255","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1750-3639.2008.00198.x","article-title":"A comparative study of \u03b1-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of \u03b1-dystroglycan does not consistently correlate with clinical severity","volume":"19","author":"Jimenez-Mallebrera","year":"2009","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nmd.2007.08.002","article-title":"Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies","volume":"18","author":"Manya","year":"2008","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0265","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajhg.2009.06.006","article-title":"Deficiency of Dol-P-man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the Dystroglycanopathies","volume":"85","author":"Lefeber","year":"2009","journal-title":"Am. J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.bbagen.2020.129652_bb0270","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nmd.2019.05.004","article-title":"Dilated cardiomyopathy and limb-girdle muscular dystrophy-dystroglycanopathy due to novel pathogenic variants in the DPM3 gene","volume":"29","author":"Svahn","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbagen.2020.129652_bb0275","unstructured":"Glycosylphosphatidylinositol Anchors - Essentials of Glycobiology - NCBI Bookshelf [Internet]."},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0280","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/cge.13425","article-title":"Clinical variability in inherited glycosylphosphatidylinositol deficiency disorders","volume":"95","author":"Bellai-Dussault","year":"2019","journal-title":"Clin. Genet."},{"issue":"7","key":"10.1016\/j.bbagen.2020.129652_bb0285","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nm1410","article-title":"Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency","volume":"12","author":"Almeida","year":"2006","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0290","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41467-017-02799-0","article-title":"Identification of a Golgi GPI-N-acetylgalactosamine transferase with tandem transmembrane regions in the catalytic domain","volume":"9","author":"Hirata","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbagen.2020.129652_bb0295","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ajhg.2019.06.009","article-title":"Mutations in PIGU impair the function of the GPI Transamidase complex, causing severe intellectual disability, epilepsy, and brain anomalies","volume":"105","author":"Knaus","year":"2019","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.bbagen.2020.129652_bb0300","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1038\/s41436-019-0512-3","article-title":"PIGT-CDG, a disorder of the glycosylphosphatidylinositol anchor: description of 13 novel patients and expansion of the clinical characteristics","volume":"21","author":"Bayat","year":"2019","journal-title":"Genet Med."},{"issue":"7","key":"10.1016\/j.bbagen.2020.129652_bb0305","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ng.3578","article-title":"NANS-mediated synthesis of sialic acid is required for brain and skeletal development","volume":"48","author":"van Karnebeek","year":"2016","journal-title":"Nat. Genet."},{"issue":"18","key":"10.1016\/j.bbagen.2020.129652_bb0310","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1212\/WNL.0000000000006932","article-title":"A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy","volume":"92","author":"Lochm\u00fcller","year":"2019","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0315","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/clinchem\/47.1.132","article-title":"Congenital disorder of glycosylation Ia with deficient phosphomannomutase activity but normal plasma glycoprotein pattern","volume":"47","author":"Dupre","year":"2001","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.bbagen.2020.129652_bb0320","first-page":"908","article-title":"SLC35A2-CDG: functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported individuals","volume":"40","author":"Ng","year":"2019","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.bbagen.2020.129652_bb0325","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/abio.1995.1475","article-title":"Effect of separation conditions on automated isoelectric focusing of carbohydrate-deficient transferrin and other human isotransferrins using the PhastSystem","volume":"230","author":"Hackler","year":"1995","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbagen.2020.129652_bb0330","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jchromb.2019.01.004","article-title":"Transferrin glycosylation analysis from dried blood spot cards and capillary blood samples","volume":"1106\u20131107","author":"Wolking","year":"2019","journal-title":"J. Chromatogr. B"},{"issue":"4","key":"10.1016\/j.bbagen.2020.129652_bb0335","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10545-011-9311-y","article-title":"Transferrin mutations at the glycosylation site complicate diagnosis of congenital disorders of glycosylation type I","volume":"34","author":"Guillard","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.bbagen.2020.129652_bb0340","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1023\/B:BOLI.0000042982.82131.a4","article-title":"Improvement of CDG diagnosis by combined examination of several glycoproteins","volume":"27","author":"Fang","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"issue":"11","key":"10.1016\/j.bbagen.2020.129652_bb0345","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1373\/clinchem.2003.023341","article-title":"Improved HPLC method for carbohydrate-deficient transferrin in serum","volume":"49","author":"Helander","year":"2003","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.bbagen.2020.129652_bb0350","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1373\/clinchem.2003.029629","article-title":"Testing for congenital disorders of glycosylation by HPLC measurement of serum transferrin glycoforms","volume":"50","author":"Helander","year":"2004","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.bbagen.2020.129652_bb0355","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.clinbiochem.2008.12.013","article-title":"Screening for congenital disorders of glycosylation (CDG): transferrin HPLC versus isoelectric focusing (IEF)","volume":"42","author":"Quintana","year":"2009","journal-title":"Clin. Biochem."},{"issue":"24","key":"10.1016\/j.bbagen.2020.129652_bb0360","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.jchromb.2009.06.031","article-title":"Comparison between high performance liquid chromatography and capillary zone electrophoresis for the diagnosis of congenital disorders of glycosylation","volume":"877","author":"Quintana","year":"2009","journal-title":"J. Chromatogr. B"},{"issue":"11","key":"10.1016\/j.bbagen.2020.129652_bb0365","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/elps.201200653","article-title":"Determination of carbohydrate-deficient transferrin in human serum by capillary zone electrophoresis: evaluation of assay performance and quality assurance over a 10-year period in the routine arena","volume":"34","author":"Joneli","year":"2013","journal-title":"Electrophoresis."},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0370","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1373\/clinchem.2003.021568","article-title":"Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis of serum transferrin","volume":"50","author":"Carchon","year":"2004","journal-title":"Clin. Chem."},{"issue":"13","key":"10.1016\/j.bbagen.2020.129652_bb0375","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/jssc.201800082","article-title":"High-resolution capillary zone electrophoresis for transferrin glycoform analysis associated with congenital disorders of glycosylation","volume":"41","author":"Tobler","year":"2018","journal-title":"J. Sep. Sci."},{"issue":"6","key":"10.1016\/j.bbagen.2020.129652_bb0380","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/0004563218779609","article-title":"Fast screening of N-glycosylation disorders by sialotransferrin profiling with capillary zone electrophoresis","volume":"55","author":"Kingma","year":"2018","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bbagen.2020.129652_bb0385","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.chroma.2017.12.002","article-title":"A capillary zone electrophoresis method for detection of apolipoprotein C-III glycoforms and other related artifactually modified species","volume":"1532","author":"Ruel","year":"2018","journal-title":"J. Chromatogr. A"},{"issue":"12","key":"10.1016\/j.bbagen.2020.129652_bb0390","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/glycob\/cwj017","article-title":"Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups","volume":"15","author":"Wopereis","year":"2005","journal-title":"Glycobiology."},{"issue":"2","key":"10.1016\/j.bbagen.2020.129652_bb0395","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1096\/fj.201800387R","article-title":"Involvement of thapsigargin\u2013 and cyclopiazonic acid\u2013sensitive pumps in the rescue of TMEM165-associated glycosylation defects by Mn2+","volume":"33","author":"Houdou","year":"2018","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.bbagen.2020.129652_bb0400","first-page":"1137","article-title":"A new mouse model of limb-girdle muscular dystrophy type 2I homozygous for the common L276I mutation mimicking the mild phenotype in humans","volume":"74","author":"Krag TO","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.bbagen.2020.129652_bb0405","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1212\/NXG.0000000000000112","article-title":"Muscle involvement in limb-girdle muscular dystrophy with GMPPB deficiency (LGMD2T)","volume":"2","author":"Oestergaard","year":"2016","journal-title":"Neurol Genet."},{"issue":"9","key":"10.1016\/j.bbagen.2020.129652_bb0410","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/clinchem\/45.9.1408","article-title":"Microheterogeneity of serum glycoproteins in patients with chronic alcohol abuse compared with carbohydrate-deficient glycoprotein syndrome type I","volume":"45","author":"Henry","year":"1999","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0415","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1615-9861(200201)2:1<3::AID-PROT3>3.0.CO;2-R","article-title":"Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains","volume":"2","author":"Rabilloud","year":"2002","journal-title":"Proteomics."},{"issue":"7","key":"10.1016\/j.bbagen.2020.129652_bb0420","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tibtech.2017.04.010","article-title":"Glycoproteomics: a balance between high-throughput and in-depth analysis","volume":"35","author":"Yang","year":"2017","journal-title":"Trends Biotechnol."},{"issue":"17","key":"10.1016\/j.bbagen.2020.129652_bb0425","doi-asserted-by":"crossref","first-page":"7886","DOI":"10.1021\/acs.chemrev.7b00732","article-title":"Mass spectrometry approaches to Glycomic and Glycoproteomic analyses","volume":"118","author":"Ruhaak","year":"2018","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.bbagen.2020.129652_bb0430","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10545-018-0144-9","article-title":"Clinical glycomics for the diagnosis of congenital disorders of glycosylation","volume":"41","author":"Abu Bakar","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.bbagen.2020.129652_bb0435","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajhg.2013.10.024","article-title":"Solving glycosylation disorders: fundamental approaches reveal complicated pathways","volume":"94","author":"Freeze","year":"2014","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.bbagen.2020.129652_bb0440","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/glycob\/cwj021","article-title":"Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia","volume":"15","author":"Sturiale","year":"2005","journal-title":"Glycobiology."},{"issue":"2\u20133","key":"10.1016\/j.bbagen.2020.129652_bb0445","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1024476915278","article-title":"Mass spectrometric analysis of glycans in elucidating the pathogenesis of CDG type IIx","volume":"26","author":"Mills","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 6","key":"10.1016\/j.bbagen.2020.129652_bb0450","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.21037\/atm.2019.08.04","article-title":"Integrating mass spectrometry-based plasma (or serum) protein N-glycan profiling into the clinical practice?","volume":"7","author":"Bruneel","year":"2019","journal-title":"Ann Transl Med."},{"issue":"4","key":"10.1016\/j.bbagen.2020.129652_bb0455","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1373\/clinchem.2010.153635","article-title":"Plasma N-glycan profiling by mass spectrometry for congenital disorders of glycosylation type II","volume":"57","author":"Guillard","year":"2011","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0460","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1373\/clinchem.2015.243279","article-title":"A novel N-Tetrasaccharide in patients with congenital disorders of glycosylation, including asparagine-linked glycosylation protein 1, Phosphomannomutase 2, and mannose phosphate isomerase deficiencies","volume":"62","author":"Zhang","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbagen.2020.129652_bb0465","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cca.2019.02.013","article-title":"Fontes N do C, Santos SCL, Lefeber DJ, Bloch C, Brum JM, et al. relative quantification of plasma N-glycans in type II congenital disorder of glycosylation patients by mass spectrometry","volume":"492","author":"Barbosa","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"16","key":"10.1016\/j.bbagen.2020.129652_bb0470","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1002\/pmic.200800163","article-title":"Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation","volume":"8","author":"Arnold","year":"2008","journal-title":"Proteomics."},{"issue":"4","key":"10.1016\/j.bbagen.2020.129652_bb0475","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/prca.200900170","article-title":"Liver proteins as sensor of human malignancies and inflammation","volume":"4","author":"Peracaula","year":"2010","journal-title":"Proteomics Clin. Appl."},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0480","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1373\/clinchem.2015.248518","article-title":"Protein-specific Glycoprofiling for patient diagnostics","volume":"62","author":"Lefeber","year":"2016","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0485","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/acs.jproteome.9b00348","article-title":"Heritability of human plasma N-Glycome","volume":"19","author":"Zaytseva","year":"2020","journal-title":"J. Proteome Res."},{"issue":"6","key":"10.1016\/j.bbagen.2020.129652_bb0490","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.trsl.2015.07.005","article-title":"High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation","volume":"166","author":"van Scherpenzeel","year":"2015","journal-title":"Transl. Res."},{"issue":"9","key":"10.1016\/j.bbagen.2020.129652_bb0495","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.bbapap.2014.05.002","article-title":"Advances in LC-MS\/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome","volume":"1844","author":"Thaysen-Andersen","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.bbagen.2020.129652_bb0500","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1074\/mcp.M700361-MCP200","article-title":"N-glycosylation site occupancy in serum glycoproteins using multiple reaction monitoring liquid chromatography-mass spectrometry","volume":"6","author":"H\u00fclsmeier","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbagen.2020.129652_bb0505","doi-asserted-by":"crossref","first-page":"33927","DOI":"10.1038\/srep33927","article-title":"Glycosylation site occupancy in health, congenital disorder of glycosylation and fatty liver disease","volume":"6","author":"H\u00fclsmeier","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bbagen.2020.129652_bb0510","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1021\/acs.analchem.9b00776","article-title":"Site-specific glycosylation quantitation of 50 serum glycoproteins enhanced by predictive Glycopeptidomics for improved disease biomarker discovery","volume":"91","author":"Li","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbagen.2020.129652_bb0515","doi-asserted-by":"crossref","first-page":"11600","DOI":"10.1038\/ncomms11600","article-title":"ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation","volume":"7","author":"Jansen","year":"2016","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bbagen.2020.129652_bb0520","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/pmic.200600977","article-title":"A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis","volume":"7","author":"Faid","year":"2007","journal-title":"Proteomics."},{"issue":"2","key":"10.1016\/j.bbagen.2020.129652_bb0525","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ab.2013.07.037","article-title":"Serum N-glycan and O-glycan analysis by mass spectrometry for diagnosis of congenital disorders of glycosylation","volume":"442","author":"Xia","year":"2013","journal-title":"Anal. Biochem."},{"issue":"6","key":"10.1016\/j.bbagen.2020.129652_bb0530","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jms.3936","article-title":"MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG","volume":"52","author":"Palmigiano","year":"2017","journal-title":"J. Mass Spectrom."},{"issue":"5","key":"10.1016\/j.bbagen.2020.129652_bb0535","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1021\/ac3034757","article-title":"Relative quantitation of glycoisoforms of intact apolipoprotein C3 in human plasma by liquid chromatography-high-resolution mass spectrometry","volume":"85","author":"Jian","year":"2013","journal-title":"Anal. Chem."},{"issue":"6","key":"10.1016\/j.bbagen.2020.129652_bb0540","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/pmic.201200293","article-title":"Mapping O-glycosylation of apolipoprotein C-III in MALDI-FT-ICR protein profiles","volume":"13","author":"Nicolardi","year":"2013","journal-title":"Proteomics."},{"key":"10.1016\/j.bbagen.2020.129652_bb0545","doi-asserted-by":"crossref","first-page":"43728","DOI":"10.1038\/srep43728","article-title":"HDL glycoprotein composition and site-specific glycosylation differentiates between clinical groups and affects IL-6 secretion in lipopolysaccharide-stimulated monocytes","volume":"7","author":"Krishnan","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bbagen.2020.129652_bb0550","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1002\/ajmg.a.37950","article-title":"A novel mutation in PIGW causes glycosylphosphatidylinositol deficiency without hyperphosphatasia","volume":"170","author":"Hogrebe","year":"2016","journal-title":"Am. J. Med. Genet. A"},{"issue":"5","key":"10.1016\/j.bbagen.2020.129652_bb0555","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1212\/01.wnl.0000284605.27654.5a","article-title":"Diagnosis and etiology of congenital muscular dystrophy","volume":"71","author":"Peat","year":"2008","journal-title":"Neurology."},{"key":"10.1016\/j.bbagen.2020.129652_bb0560","article-title":"Cutis laxa, exocrine pancreatic insufficiency and altered cellular metabolomics as additional symptoms in a new patient with ATP6AP1-CDG","volume":"11","author":"Dimitrov","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.bbagen.2020.129652_bb0565","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ajhg.2019.03.003","article-title":"The metabolic map into the Pathomechanism and treatment of PGM1-CDG","volume":"104","author":"Radenkovic","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbagen.2020.129652_bb0570","doi-asserted-by":"crossref","first-page":"115702","DOI":"10.1016\/j.trac.2019.115702","article-title":"Practical sample pretreatment techniques coupled with capillary electrophoresis for real samples in complex matrices","volume":"122","author":"Jarvas","year":"2020","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.bbagen.2020.129652_bb0575","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.trac.2018.02.005","article-title":"Recent advances in biological sample preparation methods coupled with chromatography, spectrometry and electrochemistry analysis techniques","volume":"102","author":"Niu","year":"2018","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.bbagen.2020.129652_bb0580","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jpba.2018.07.051","article-title":"Immobilized enzyme-based analytical tools in the -omics era: recent advances","volume":"160","author":"Naldi","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.bbagen.2020.129652_bb0585","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/btpr.2385","article-title":"Recent advances in immobilization strategies for Glycosidases","volume":"33","author":"Karav","year":"2017","journal-title":"Biotechnol. Prog."},{"issue":"12","key":"10.1016\/j.bbagen.2020.129652_bb0590","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1021\/ac501573g","article-title":"Rapid magnetic bead based sample preparation for automated and high throughput N-glycan analysis of therapeutic antibodies","volume":"86","author":"V\u00e1radi","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbagen.2020.129652_bb0595","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.snb.2017.09.003","article-title":"Single-step immunoassays and microfluidic droplet operation: towards a versatile approach for detection of amyloid-\u03b2 peptide-based biomarkers of Alzheimer\u2019s disease","volume":"255","author":"Mai","year":"2018","journal-title":"Sensors Actuators B Chem."},{"key":"10.1016\/j.bbagen.2020.129652_bb0600","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.aca.2018.11.002","article-title":"A streamlined strategy for rapid and selective analysis of serum N-glycome","volume":"1050","author":"Peng","year":"2019","journal-title":"Anal. Chim. Acta"},{"issue":"6","key":"10.1016\/j.bbagen.2020.129652_bb0605","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/rcm.7125","article-title":"Evaluation of a combined glycomics and glycoproteomics approach for studying the major glycoproteins present in biofluids: application to cerebrospinal fluid","volume":"29","author":"Goyallon","year":"2015","journal-title":"Rapid Commun. Mass Spectrom."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416520301641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416520301641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:05:54Z","timestamp":1759637154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416520301641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":121,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0304416520301641"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2020.129652","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CDG biochemical screening: Where do we stand?","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2020.129652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129652"}}